News briefing: Novartis hands off NASH drug to biotech collaborator, also plans to build new Basel production unit
After building up its work on NASH, Novartis is handing over one of its candidates to Boston Pharmaceuticals.
The private …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.